Influx Healthtech Ltd., which launched its initial public offering (IPO) on Wednesday, was booked over 5 times on Day 1. The demand for the issue was led by retail investors who subscribed 8.46 times.
The company aims to raise more than Rs 55 crore from the primary market.
As subscription for the SME issue enters day 2, here's all you need to know about the Influx Healthtech IPO, including the latest grey market premium, Day 2 subscription status, price band and more.
Influx Healthtech IPO: All You Need To Know
The Influx Healthtech IPO is a book-building issue worth Rs 55.63 crore. It comprises a fresh issue of 46.94 lakh shares, worth Rs 45.07 crore, and an offer-for-sale of 11 lakh shares, amounting to Rs 10.56 crore.
The price band for the IPO has been fixed between Rs 91 and Rs 96 per share.
Retail investors can invest in the IPO by bidding for a single lot size of 1200 shares, requiring an investment of Rs 1,15,200.
Of the 43,64,400 shares on offer
11,59,200 (26.56%) are allocated to Qualified Institutional investors
8,70,000 (19.93%) are allocated to Non-Institutional investors
20,29,200 (46.49%) are allocated to Retail investors
The Influx Healthtech IPO will remain open for subscription from till June 20. The allotment of shares is scheduled to be finalised on June 23. Successful bidders will receive the shares in their Demat accounts on June 24. Refunds for non-allottees will also be processed on the same day.
Influx Healthtech's IPO listing is scheduled for June 25. Shares of Influx Healthtech Ltd. will be listed on the NSE SME platform.
Rarever Financial Advisors Pvt. is the book-running lead manager of the Influx Healthtech IPO. Maashitla Securities Pvt. is the registrar and RK Stock Holding Pvt. is the market maker for the issue.
Influx Healthtech IPO GMP Today
According to InvestorGain, the grey market premium (GMP) for the Influx Healthtech IPO was Rs 38 as of 5:00 p.m. on June 19. The latest GMP indicates it will list at Rs 134 per share, at a premium of 39.58% apiece on the upper end of the price band.
Note: GMP does not represent official data and is based on speculation.
Influx Healthtech IPO Day Two Subscription Status
The Influx Healthtech IPO has been subscribed 25.38 times as of 5:40 p.m. on Thursday.
Qualified Institutional Buyers: 1.69 times
Non-Institutional Investors: 32.26 times
Retail Investors: 35.97 times
*The subscription status will be updated at regular intervals
About Influx Healthtech
The company is a manufacturer of healthcare products. Its portfolio includes nutraceuticals, cosmetics, Ayurvedic and veterinary feed supplements.
The company will use proceeds from the IPO to set up manufacturing facilities, buy machinery and for general corporate purposes.
The company's profit after tax (PAT) rose 20.1% year-on-year (YoY) to Rs 13.37 crore in FY25 from Rs 11.13 crore in FY24. Revenue from operations increased 4.9% YoY to Rs 104.85 crore in FY25 from Rs 99.96 crore in FY24.
Disclaimer: Investments in initial public offerings are subject to market risks. Please consult with financial advisors and read the red herring prospectus thoroughly before placing bids.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
